Literature DB >> 15235205

Cerebellar medulloblastoma presenting with skeletal metastasis.

Sukanta Barai1, G P Bandopadhayaya, P K Julka, H Dhanapathi, A K Haloi, A Seith.   

Abstract

Medulloblastomas are highly malignant brain tumours, but only rarely produce skeletal metastases. No case of medulloblastoma has been documented to have produced skeletal metastases prior to craniotomy or shunt surgery. A 21-year-old male presented with pain in the hip and lower back with difficulty in walking of 3 months' duration. Signs of cerebellar dysfunction were present hence a diagnosis of cerebellar neoplasm or skeletal tuberculosis with cerebellar abscess formation was considered. MRI of brain revealed a lesion in the cerebellum suggestive of medulloblastoma. Bone scan revealed multiple sites of skeletal metastases excluding the lumbar vertebrae. MRI of lumbar spine and hip revealed metastases to all lumbar vertebrae and both hips. Computed tomography-guided biopsy was obtained from the L3 vertebra, which revealed metastatic deposits from medulloblastoma. Cerebrospinal fluid cytology showed the presence of medulloblastoma cells. A final diagnosis of cerebellar medulloblastoma with skeletal metastases was made. He underwent craniotomy and histopathology confirmed medulloblastoma.

Entities:  

Mesh:

Year:  2004        PMID: 15235205

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  3 in total

1.  Supratentorial primitive neuroectodermal tumor metastasis to the abdomen via a ventriculoperitoneal shunt.

Authors:  David T Boyd; Mohammad R Hayeri; Pranav K Vyas
Journal:  Pediatr Radiol       Date:  2010-06-05

2.  [Differential diagnosis of space demands in the cerebellopontine angle].

Authors:  B Holst; I Q Grunwald; G Brill; W Reith
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

3.  Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma.

Authors:  Yong Gao; Puxian Li; Zhenrui Liu; Xingtao Diao; Chunyun Song
Journal:  Exp Ther Med       Date:  2015-10-16       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.